| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 29, 2026 | ±2.2% | -0.1% | over-priced |
| December 2, 2025 | ±1.9% | -0.7% | over-priced |
| August 29, 2025 | ±1.5% | -0.4% | over-priced |
| May 30, 2025 | ±2.1% | -0.1% | over-priced |
| December 4, 2024 | ±1.5% | +0.6% | over-priced |
| May 31, 2024 | ±1.9% | -0.3% | over-priced |
| November 29, 2023 | ±1.3% | -1.2% | over-priced |
| August 25, 2023 | ±1.7% | +0.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | $1.19 | $14.3B | $1.3B |
| Q4 FY2026 | $1.57 | $17.7B | $1.8B |
| Q3 FY2026 | $1.28 | $15.1B | $1.4B |
| Q2 FY2026 | $1.10 | $14.4B | $1.2B |
TJX Companies, Inc. (The) (TJX) reports in 120 days, with the next report estimated for October 11, 2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 0.5% on average — the market has systematically over-priced TJX's earnings risk. Fundamentals into the print: EPS up 29.3% year-over-year, revenue up 9.2%. QuantLogix's live 5-factor engine currently reads TJX as a buy at 57/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →